Related references
Note: Only part of the references are listed.p53: 800 million years of evolution and 40 years of discovery
Arnold J. Levine
NATURE REVIEWS CANCER (2020)
Modeling the regulation of p53 activation by HIF-1 upon hypoxia
Ping Wang et al.
FEBS LETTERS (2019)
Regulatory mechanisms of hypoxia-inducible factor 1 activity: Two decades of knowledge
Sho Koyasu et al.
CANCER SCIENCE (2018)
ZBTB2 reads unmethylated CpG island promoters and regulates embryonic stem cell differentiation
Ino D. Karemaker et al.
EMBO REPORTS (2018)
HIF-1 maintains a functional relationship between pancreatic cancer cells and stromal fibroblasts by upregulating expression and secretion of Sonic hedgehog
Tomohiro Katagiri et al.
Oncotarget (2018)
p53 mutants cooperate with HIF-1 in transcriptional regulation of extracellular matrix components to promote tumor progression
Ivano Amelio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
A circadian clock gene, PER2, activates HIF-1 as an effector molecule for recruitment of HIF-1α to promoter regions of its downstream genes
Minoru Kobayashi et al.
FEBS JOURNAL (2017)
LY6E: a conductor of malignant tumor growth through modulation of the PTEN/PI3K/Akt/HIF-1 axis
Chan Joo Yeom et al.
ONCOTARGET (2016)
ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB
James A. Maier et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2015)
UCHL1 provides diagnostic and antimetastatic strategies due to its deubiquitinating effect on HIF-1α
Yoko Goto et al.
NATURE COMMUNICATIONS (2015)
Aberrant IDH3α expression promotes malignant tumor growth by inducing HIF-1-mediated metabolic reprogramming and angiogenesis
L. Zeng et al.
ONCOGENE (2015)
Identification of Candidate Oncogenes in Human Colorectal Cancers With Microsatellite Instability
Alexandra E. Gylfe et al.
GASTROENTEROLOGY (2013)
Stromal plasma cells expressing immunoglobulin G4 subclass in non-small cell Lung cancer
Masakazu Fujimoto et al.
HUMAN PATHOLOGY (2013)
The CEACAM1 tumor suppressor is an ATM and p53-regulated gene required for the induction of cellular senescence by DNA damage
A-P Sappino et al.
ONCOGENESIS (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
G. L. Semenza
ONCOGENE (2010)
ZBTB2, a Novel Master Regulator of the p53 Pathway
Bu-Nam Jeon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The SWISS-MODEL Repository and associated resources
Florian Kiefer et al.
NUCLEIC ACIDS RESEARCH (2009)
p53 polymorphisms: cancer implications
Catherine Whibley et al.
NATURE REVIEWS CANCER (2009)
Regulation of hypoxia-inducible factor 1 by prolyl and asparaginyl hydroxylases
K Hirota et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Scalable molecular dynamics with NAMD
JC Phillips et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)
Hypoxia-inducible factor-1-mediated activation of stanniocalcin-1 in human cancer cells
HY Yeung et al.
ENDOCRINOLOGY (2005)
Asparagine hydroxylation of the HIF transactivation domain: A hypoxic switch
D Lando et al.
SCIENCE (2002)
FIH-1:: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity
PC Mahon et al.
GENES & DEVELOPMENT (2001)
HIFα targeted for VHL-mediated destruction by proline hydroxylation:: Implications for O2 sensing
M Ivan et al.
SCIENCE (2001)
Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation
P Jaakkola et al.
SCIENCE (2001)
Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel-Lindau protein
M Ohh et al.
NATURE CELL BIOLOGY (2000)
Share Paper
